Clinical Trials

Brightline-4: A Phase III Open-label, Single-arm, Multi-center Study to Assess the Safety and Efficacy of Brigimadlin (BI 907828) Treatment in Patients With Treatment-naïve or Pre-treated Advanced Dedifferentiated Liposarcoma

Link : https://clinicaltrials.gov/ct2/show/NCT06058793
Status : CLOSED
Population : DDLPS any line
Description : Brigimadlin (MDM2i)
PI : A. Razak
Centers Opened : PMH
Phase : Drug access trial
IIST/Pharma : Pharma